HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers.

AbstractBACKGROUND:
Serum levels of a secreted glycoprotein YKL-40 are elevated in patients with a wide range of cancers including breast, colorectal, and ovarian cancers. Furthermore, these increased levels correlate with poorer survival of cancer patients, suggesting that serum levels of YKL-40 might be a prognostic biomarker. However, the tissue expression of YKL-40 and its relationship with clinical outcomes and other potential markers are poorly understood.
METHODS:
Tissue samples from invasive breast cancers, breast ductal carcinoma in situ (DCIS), and cancer-free reduction mammoplasty were enrolled. YKL-40 expression was measured using immunohistochemistry and evaluated by a semi-quantification assay. Statistical analyses explored the relationship of YKL-40 with clinical outcome and other breast cancer biomarkers.
RESULTS:
Breast ductal carcinoma in situ expressed low and moderate levels of YKL-40. In the subset of 203 patients with invasive cancer, YKL-40 levels were positively correlated with tumour grade (P<0.0001) and Her2/neu (P<0.01), but negatively correlated with oestrogen (P<0.0001) and progesterone receptor (P<0.0001). YKL-40 levels were inversely correlated with expressions of GATA3 (P=0.0137) and E-cadherin (P=0.0417).
CONCLUSION:
These data demonstrate that expression levels of YKL-40 are associated with tumour grade, poor differentiation, and other breast cancer markers, highlighting that tissue levels of YKL-40 serve as a valuable biomarker for breast cancer diagnosis and prognosis.
AuthorsR Shao, Q J Cao, R B Arenas, C Bigelow, B Bentley, W Yan
JournalBritish journal of cancer (Br J Cancer) Vol. 105 Issue 8 Pg. 1203-9 (Oct 11 2011) ISSN: 1532-1827 [Electronic] England
PMID21934681 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Adipokines
  • Biomarkers, Tumor
  • CHI3L1 protein, human
  • Chitinase-3-Like Protein 1
  • Lectins
Topics
  • Adipokines (blood, immunology)
  • Adult
  • Antibody Specificity
  • Biomarkers, Tumor (blood)
  • Breast Neoplasms (blood, pathology)
  • Carcinoma, Intraductal, Noninfiltrating (blood)
  • Cell Differentiation
  • Chitinase-3-Like Protein 1
  • Female
  • Humans
  • Immunohistochemistry
  • Lectins (blood, immunology)
  • Middle Aged
  • Paraffin Embedding
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: